Avid Delivers Social Media Innovations to Maximize Audience Engagement
Feb 09, 2017 13:02 pm UTC| Business
BURLINGTON, Mass., Feb. 09, 2017 -- Avid® (Nasdaq:AVID) today announced that Social Media Hub now offers native integration with MediaCentral® | UX, the cloud-based web front end to the Avid MediaCentral Platform, the...
Avid Delivers Social Media Innovations to Maximize Audience Engagement
Feb 09, 2017 13:02 pm UTC| Business
BURLINGTON, Mass., Feb. 09, 2017 -- Avid® (Nasdaq:AVID) today announced that Social Media Hub now offers native integration with MediaCentral® | UX, the cloud-based web front end to the Avid MediaCentral Platform, the...
Avid Delivers Social Media Innovations to Maximize Audience Engagement
Feb 09, 2017 13:02 pm UTC| Business
BURLINGTON, Mass., Feb. 09, 2017 -- Avid® (Nasdaq:AVID) today announced that Social Media Hub now offers native integration with MediaCentral® | UX, the cloud-based web front end to the Avid MediaCentral Platform, the...
Immunomedics Announces Conference Call and Webcast for Second Quarter Fiscal 2017 Results
Feb 09, 2017 13:02 pm UTC| Business
MORRIS PLAINS, N.J., Feb. 09, 2017 -- Immunomedics, Inc., (NASDAQ:IMMU) (“Immunomedics” or “the Company”) today announced that it will report financial results for the second quarter ended December 31, 2016 after the...
Immunomedics Announces Conference Call and Webcast for Second Quarter Fiscal 2017 Results
Feb 09, 2017 13:02 pm UTC| Business
MORRIS PLAINS, N.J., Feb. 09, 2017 -- Immunomedics, Inc., (NASDAQ:IMMU) (“Immunomedics” or “the Company”) today announced that it will report financial results for the second quarter ended December 31, 2016 after the...
Immunomedics Announces Conference Call and Webcast for Second Quarter Fiscal 2017 Results
Feb 09, 2017 13:02 pm UTC| Business
MORRIS PLAINS, N.J., Feb. 09, 2017 -- Immunomedics, Inc., (NASDAQ:IMMU) (“Immunomedics” or “the Company”) today announced that it will report financial results for the second quarter ended December 31, 2016 after the...
Feb 09, 2017 13:02 pm UTC| Business
Hancock, MD, Feb. 09, 2017 -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the Company), a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, augments the advisory...